Skip to main navigation

Medpace Corporate

Careers
Investors
Investigators
Study Participants
Blog
Japan Site
Login

About
About

Our mission is to accelerate the development of safe and effective medical therapeutics.

Company Overview
Services & Capabilities Brochure: Trusted by Biotech Read More

Whitepaper Winning at Your Drug Development Strategy – A Playbook for Emerging Biotechs Read More
CRO
CRO

Medpace helps biotechs accelerate the development of their medical therapeutics with a full breadth of services and collaborative model.

Services Overview
Whitepaper A Collaborative Framework for Achieving Diversity, Equity, and Inclusion (DEI) in Clinical Trial Populations Read More

Whitepaper Benefits and Challenges of Continuous Glucose Monitoring (CGM) in Clinical Development Read More
Therapeutics
Therapeutics

Our therapeutically-focused model gives sponsors early and ongoing insight from medical experts throughout trial design and execution, and facilitates collaboration across specialties to incorporate various medical perspectives and considerations.

Our Approach

Request Information
Blog [Webinar] Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials Read More

Webinar Successful Approaches from Rare Disease and Cellular and Gene Therapy Product Approvals Read More
- Therapeutic Depth
  Autoimmune & Inflammation
  Cardiovascular
  Dermatology
  Endocrine & Metabolic
  Gastroenterology & Hepatology
  Hematology & Oncology
  Infectious Diseases & Vaccines
  Non-Alcoholic Steatohepatitis
  Nephrology & Renal Disease
  Neuroscience
  Ophthalmology
- Crossovers
  Rare Diseases
  Cell & Gene Therapy
  Radiation Therapy
  Women’s Health
  Pediatrics
  Medical Device & Diagnostics
Labs
Labs

Medpace offers comprehensive and fully-integrated central and bioanalytical laboratory services that deliver efficient and streamlined execution.

Integrated for Efficiency

Take a Tour
Webinar Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays Read More

Article The Utility of Liquid Biopsy in Oncology Clinical Trials Read More
- Central Lab
  Capabilities
  Biomarkers
  Safety Testing
  Featured Methods
  Therapeutic Expertise
  Biorepository Services
  Accreditations
  Test Directory
- Bioanalytical Lab
  Capabilities
  Discovery & Development
  Preclinical Studies
  PK Studies
  TK Studies
  Biomarker Assays
  ADA Assays
  Neutralizing Antibody Assays
  Bioanalytical Assays and Posters
Core Labs
Core Labs

Medpace Core Labs provide an end-to-end suite of global cardiac safety and imaging services to enhance and expedite biopharmaceutical and medical device development.

Request Information
Article Expert Insights: Q&A with Dr. Satya Shreenivas, Cardiovascular Expert Read More

Webinar Integrating Wearable Remote Biosensor Technology into Decentralized Clinical Trials Read More
Phase I Unit
Insights
Contact

HomeInvestorsFinancials & FilingsSEC Filings4

SEC Filing Details

Skip to content

Investor Relations

Overview
News Releases
Events & Presentations
Financials & Filings
Stock Information
- Stock Quote & Chart
- Historical Price Lookup
Corporate Governance
Corporate Responsibility Report
Investor Resources
Investor FAQs

Shareholder Tools

Print Page
RSS Feeds
Email Alerts

Document Details

Form

Filing Date

Dec 13, 2022

Document Date

Dec 9, 2022

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

Medpace Holdings, Inc.

Issuer

Medpace Holdings, Inc.

Filer

Kraft Robert O.

Filing Formats

View HTML

Medpace, Inc.
5400 Medpace Way, Cincinnati, Ohio 45227 USA
Toll-free: +1.800.730.5779
Tel: +1.513.579.9911

Social Media Links

Facebook
LinkedIn
YouTube
Vimeo

© 2024 Medpace Holdings, Inc., All Rights Reserved
Privacy Policy
Accessibility Statement
UK Modern Slavery Act
Terms of Use
Sitemap